Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2024 | 10-2023 | 10-2022 | 12-2021 | 10-2021 | |
| Operating Expenses | 5,745 | 6,303 | 6,251 | 3,362 | 3,362 |
| Operating Income | -5,745 | -6,303 | -6,251 | -3,362 | -3,362 |
| Interest Expense | 36 | 11 | 0 | 15 | 15 |
| Other Income | 904 | -2,289 | -614 | -3,902 | -3,902 |
| Pre-tax Income | -4,877 | -8,604 | -6,865 | -7,279 | -7,279 |
| Income Tax | 378 | 17 | 30 | 32 | 32 |
| Net Income Continuous | -5,255 | -8,621 | -6,895 | -7,310 | -7,310 |
| Net Income | $-5,255 | $-8,621 | $-6,895 | $-7,310 | $-7,310 |
| EPS Basic Total Ops | -67.60 | -1,703.20 | -6,364.40 | N/A | N/A |
| EPS Basic Continuous Ops | -67.80 | -1,707.10 | -6,364.25 | N/A | N/A |
| EPS Diluted Total Ops | -67.60 | -1,703.20 | -6,364.40 | N/A | N/A |
| EPS Diluted Continuous Ops | -67.80 | -1,707.10 | -6,364.25 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -1.69 | -42.58 | -168.77 | N/A | N/A |
| EBITDA(a) | $-5,733 | $-6,281 | $-6,229 | $-3,362 | $-3,362 |